Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
valuation ratios | |
|---|---|
| pe ratio | 0.82 |
| peg ratio | 0.09 |
| price to book ratio | 0.30 |
| price to sales ratio | 6.72 |
| enterprise value multiple | -0.41 |
| price fair value | 0.30 |
profitability ratios | |
|---|---|
| gross profit margin | -91.37% |
| operating profit margin | 1629.65% |
| pretax profit margin | 806.19% |
| net profit margin | 806.19% |
| return on assets | 29.72% |
| return on equity | -209.24% |
| return on capital employed | 67.77% |
liquidity ratio | |
|---|---|
| current ratio | 1.16 |
| quick ratio | 1.16 |
| cash ratio | 0.74 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 96.90 |
| days of payables outstanding | 181.45 |
| cash conversion cycle | -84.54 |
| receivables turnover | 3.77 |
| payables turnover | 2.01 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.10 |
| debt equity ratio | 0.12 |
| long term debt to capitalization | 0.03 |
| total debt to capitalization | 0.11 |
| interest coverage | 3.05 |
| cash flow to debt ratio | -5.28 |
cash flow ratios | |
|---|---|
| free cash flow per share | -7.98 |
| cash per share | 1.22 |
| operating cash flow per share | -7.69 |
| free cash flow operating cash flow ratio | 1.04 |
| cash flow coverage ratios | -5.28 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | -26.36 |
Frequently Asked Questions
Scinai Immunotherapeutics Ltd. (SCNI) published its most recent earnings results on 30-09-2024.
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Scinai Immunotherapeutics Ltd. (NASDAQ:SCNI)'s trailing twelve months ROE is -209.24%.
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Scinai Immunotherapeutics Ltd. (SCNI) currently has a ROA of 29.72%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
SCNI reported a profit margin of 806.19% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
Apple's current ratio, which measures its ability to pay short-term obligations, was 1.16 in the most recent quarter. The quick ratio stood at 1.16, with a Debt/Eq ratio of 0.12.